Retia Medical Announces Expansion of Clinical Advisory Board to Support Critical Advances in Hemodynamic Monitoring
Valhalla, NY – July 8, 2019 – Retia Medical, LLC, a medical device company focused on transforming the practice of critical care by making accurate hemodynamic data available and affordable for use at every bed, today announced that Ashish K. Khanna, MD, FCCP, FCCM has joined its Clinical Advisory Board. Dr. Khanna is an intensivist, anesthesiologist and associate professor of anesthesiology at the Wake Forest School of Medicine, Wake Forest Baptist Health, Winston-Salem, NC. In addition to holding multiple leadership roles within the Society of Critical Care Medicine (SCCM), and the American Society of Anesthesiologists (ASA) Dr. Khanna has written more than 60 peer reviewed papers, two dozen book chapters, many editorials and has created multiple online educational videos. His areas of work include the hemodynamic thresholds and outcomes in the critically ill, use of novel vasopressors in shock states in the ICU, and the prediction of acute cardiorespiratory compromise on the general care floor. He has previously led and continues to lead several clinical research trials, within and outside his institution and is a strong proponent of the multi-disciplinary and multi-institutional scope of critical care research. He believes that early detection of patterns using multi parameter hemodynamic and respiratory data will help develop algorithms to proactively risk predict and mitigate harm before it happens.
“We are delighted to welcome Dr. Khanna to our Clinical Advisory Board,” said Marc Zemel, S.M., M.B.A., co-founder and Chief Executive Officer of Retia Medical. “We look forward to working with him as a recognized leader in critical care to help integrate hemodynamic monitoring into clinical practice and guide our continued efforts to develop novel algorithms that improve the accuracy and utility of hemodynamic monitoring technologies.”
Retia Medical’s lead product, the Argos Cardiac Output Monitor, is highly accurate, easy-to-use and cost-effective. It is equipped with the company’s proprietary Multi-Beat Analysis™ (MBA™) Algorithm, which guarantees superior CO monitoring performance, quality, reliability, and compatibility for enhanced hemodynamic management.
About the Argos Cardiac Output Monitor
Retia Medical designed the Argos Cardiac Output (CO) Monitor to provide members of the Critical Care team in the operating room and intensive care unit with a more accurate, intuitive and affordable hemodynamic monitor that supports confident, data-based patient care decision making.
Equipped with Retia’s proprietary MBA™ algorithm, which uses advanced signal processing to improve the model of circulation and enables accurate tracking of both fluid and pressor resuscitation, the Argos Monitor seamlessly combines accuracy, ease of use, EMR connectivity and cost-effectiveness.
About Retia Medial
Retia Medical aims to advance the use of CO monitoring to improve patient care by providing members of the critical care team with a more accurate, easy-to-use, and affordable hemodynamic monitor that supports confident, data-based decisions.
Retia brings together industry-leading expertise in physiology, signal processing, and computational algorithms to engineer innovative monitoring solutions that give clinicians up-to-the-minute data that they can rely on to make informed patient care decisions. Additionally, Retia is committed to offering more clinicians access to CO monitoring by reducing the cost and inconvenience that limit the use of traditional CO technologies to the most high-risk patients. For additional information, please visit www.retiamedical.com.
Recent Press Releases:
- Retia Medical Announces the acquisition of its Argos hemodynamic monitor by Temple University
- Retia Medical awarded a Hemodynamic Monitoring Products agreement with Premier, Inc.
- Retia Medical and The JANZ Corporation Announce Strategic Partnership Agreement
- Retia Medical presenting at STS, SCCM, and Arab Health!